TRI facility · TRI 2024 reporting year

Procter & Gamble Tabler Station Manufacturing Plant

Total reported releases 992 lb fell meaningfully year over year (-24%). Total releases concentrations are up 81% since 2019.

396 DEVELOPMENT DR, Inwood, West Virginia · 325611 · Chemicals · operated by The Procter & Gamble Co

TOTAL RELEASES · 20192024
Bar chart of annual values from 2019 to 2024, in lb. Most recent year (2024): 992.20k'19'20'21'22'23'24992
Anomaly engine

Notable Signals

No notable signals at this facility for the current reporting year. See chemicals and equity context below for the full picture.

Chemicals reported · most recent year

What This Facility Releases

GENERALCAS N982

Zinc compounds

946 lb · -23% YoY

Zinc compounds concentrations are up 81% since 2019.

PBTCAS 1222-05-5

1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran

40 lb · -47% YoY

1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran concentrations have fallen 47% since 2023.

RESPIRATORYCAS N230

Certain glycol ethers

6 lb · +5% YoY

Certain glycol ethers concentrations have more than halved since 2019.

Equity context · ACS 2018-2022 block-group demographics

Who Lives Next To This Facility

Within 3 miles of this facility (8 Census block groups, population-weighted demographics): a population of 15,335. Why we surface this →

POPULATION SHARE
22.1%

Low-income

POPULATION SHARE
14.8%

People of color

POPULATION SHARE
5.5%

Under age 5

POPULATION SHARE
13.9%

Over age 64

Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.

Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.

What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.